Cardiol Therapeutics Inc. (TSX:CRDL)
1.250
-0.110 (-8.09%)
Nov 19, 2026, 4:00 PM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 146.03 million as of November 19, 2026. It is the 24,482nd most valuable company in the world and the 623rd biggest in Canada. Its market cap has increased by 3.34% in one year.
Market Cap
146.03M
Enterprise Value
116.90M
Revenue
n/a
Global Rank
Country Rank
#623 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 146.03M, an increase of 54.83%. That is a compound annual growth rate of 5.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 146.03M | 12.02% |
| Dec 31, 2025 | 130.36M | -13.65% |
| Dec 31, 2024 | 150.97M | 110.34% |
| Dec 29, 2023 | 71.77M | 63.28% |
| Dec 30, 2022 | 43.96M | -69.05% |
| Dec 31, 2021 | 142.02M | 55.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Canopy Growth | 338.68M |
| Cresco Labs | 263.38M |
| BioSyent | 201.64M |
| Cannara Biotech | 199.41M |
| Medexus Pharmaceuticals | 179.02M |
| TerrAscend | 173.00M |
| Organigram Global | 146.65M |
| Grown Rogue International | 127.47M |